233 related articles for article (PubMed ID: 22796052)
1. A biphasic endothelial stress-survival mechanism regulates the cellular response to vascular endothelial growth factor A.
Latham AM; Odell AF; Mughal NA; Issitt T; Ulyatt C; Walker JH; Homer-Vanniasinkam S; Ponnambalam S
Exp Cell Res; 2012 Nov; 318(18):2297-311. PubMed ID: 22796052
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
3. The recombinant kringle domain of urokinase plasminogen activator inhibits VEGF165-induced angiogenesis of HUVECs by suppressing VEGFR2 dimerization and subsequent signal transduction.
Kim BM; Lee DH; Choi HJ; Lee KH; Kang SJ; Joe YA; Hong YK; Hong SH
IUBMB Life; 2012 Mar; 64(3):259-65. PubMed ID: 22252975
[TBL] [Abstract][Full Text] [Related]
4. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor and soluble FLT-1 receptor interactions and biological implications.
Malecki M; Trembacz H; Szaniawska B; Przybyszewska M; Janik P
Oncol Rep; 2005 Dec; 14(6):1565-9. PubMed ID: 16273257
[TBL] [Abstract][Full Text] [Related]
7. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
Guan F; Villegas G; Teichman J; Mundel P; Tufro A
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
9. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
10. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
[TBL] [Abstract][Full Text] [Related]
12. Cellular repressor of E1A-stimulated genes regulates vascular endothelial cell migration by the ILK/AKT/mTOR/VEGF(165) signaling pathway.
Zhang H; Han Y; Tao J; Liu S; Yan C; Li S
Exp Cell Res; 2011 Dec; 317(20):2904-13. PubMed ID: 21939655
[TBL] [Abstract][Full Text] [Related]
13. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
[TBL] [Abstract][Full Text] [Related]
14. Stanniocalcin-1 and -2 promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways.
Law AY; Wong CK
Mol Cell Endocrinol; 2013 Jul; 374(1-2):73-81. PubMed ID: 23664860
[TBL] [Abstract][Full Text] [Related]
15. Associations between insulin-like growth factor I, vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnancies.
Olmos A; Díaz L; Avila E; Barrera D; López-Marure R; Biruete B; Larrea F; Halhali A
Growth Factors; 2013 Aug; 31(4):123-9. PubMed ID: 23750889
[TBL] [Abstract][Full Text] [Related]
16. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G
Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656
[TBL] [Abstract][Full Text] [Related]
17. [In vitro study of human multiple myeloma cell transfected with soluble vascular endothelial growth factor receptor-1 gene].
Zheng D; Li J; Liu JR; Zhou ZH; Gu JL
Chin J Cancer; 2010 Jan; 29(1):65-8. PubMed ID: 20038313
[TBL] [Abstract][Full Text] [Related]
18. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
[TBL] [Abstract][Full Text] [Related]
19. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.
Lorenzon E; Colladel R; Andreuzzi E; Marastoni S; Todaro F; Schiappacassi M; Ligresti G; Colombatti A; Mongiat M
Oncogene; 2012 Jun; 31(26):3136-47. PubMed ID: 22020326
[TBL] [Abstract][Full Text] [Related]
20. [Construction and expression of soluble vascular endothelial growth factor receptor-1 eukaryotic expression vector and its effect on proliferation of vascular endothelial cells].
Ji L; Mao S; Liu H; Xu S; Yang Y; Yi C; Huang Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):369-72. PubMed ID: 20481321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]